ConductScience.org, home

Paper41007442

Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants.

Zabala BA and 8 others. Biology (Basel), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants. Papers, record 41007442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007442

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants.
PubMed
Journal
Biology (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-09-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zabala BABrenda A
2Vázquez MEMaría Elisahttps://orcid.org/0000-0002-8202-3614
3Barraza DEDaniela E
4Mesías ACAndrea C
5Ramos FFederico
6Uncos AAlejandro
7Marcipar ISIván S
8Acuña LLeonardohttps://orcid.org/0000-0001-5699-4583
9Pérez Brandán CCeciliahttps://orcid.org/0000-0002-9282-0959

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2017Fundacion Florencio FioriniPubMedPubMed
2016Bunge & Born FoundationPubMedPubMed
PICT 2018-3082Agencia Nacional de Promocion Cientifica y TecnicaPubMedPubMed
PIBBA 28720210100607Consejo Nacional de Investigaciones Científicas y TécnicasPIBBA287202PubMedNIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127634183An Updated Review of ISCOMSTM and ISCOMATRIXTM Vaccines.Curr Pharm Des2016https://conductscience.org/library/papers/27634183PubMed
238481660Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/38481660PubMed
329578409Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure.Elife2018https://conductscience.org/library/papers/29578409PubMed
422705838Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool.Bioengineered2012https://conductscience.org/library/papers/22705838PubMed
529601585Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/29601585PubMed
625921214CD8+ T cells in Trypanosoma cruzi infection.Semin Immunopathol2015https://conductscience.org/library/papers/25921214PubMed
739460337Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model.Vaccines (Basel)2024https://conductscience.org/library/papers/39460337PubMed
832464684Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.Clin Exp Immunol2020https://conductscience.org/library/papers/32464684PubMed
99934965Levels of tumor necrosis factor alpha, gamma interferon, and interleukins 4,6, and 10 as determined in mice infected with virulent or attenuated strains of Trypanosoma cruzi.Parasitol Res1999https://conductscience.org/library/papers/9934965PubMed
1024551259A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/24551259PubMed
1114604574Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.Vaccine2003https://conductscience.org/library/papers/14604574PubMed
1225853654Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/25853654PubMed
1319381287Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients.PLoS Negl Trop Dis2009https://conductscience.org/library/papers/19381287PubMed
1435279330Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.Vaccine2022https://conductscience.org/library/papers/35279330PubMed
1531116244Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites.Mem Inst Oswaldo Cruz2019https://conductscience.org/library/papers/31116244PubMed
1611228380QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.Vaccine2001https://conductscience.org/library/papers/11228380PubMed
1725496192Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Expert Rev Vaccines2015https://conductscience.org/library/papers/25496192PubMed
1838612650Chagas Disease: A Silent Threat for Dogs and Humans.Int J Mol Sci2024https://conductscience.org/library/papers/38612650PubMed
193111281Field trial of vaccination against American trypanosomiasis (Chagas' disease) in domestic guinea pigs.Am J Trop Med Hyg1987https://conductscience.org/library/papers/3111281PubMed
2016556475Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.Vaccine2006https://conductscience.org/library/papers/16556475PubMed

See all 55 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42347647Long-Lasting Antibody and CD8+ Memory T Cell Responses Induced by N-Tc52/TSKb20 Vaccination upon Trypanosoma cruzi Antigen Re-Encounter.Vaccines (Basel)2026https://conductscience.org/library/papers/42347647PubMed
41893765Immunoproteomic Identification and Vaccine Assessment of Trypanosoma vivax Invariant Surface Glycoprotein.Vaccines (Basel)2026https://conductscience.org/library/papers/41893765PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007442

GET https://conductscience.org/api/papers/v1/41007442/references?page=2